Polarean Imaging (GB:POLX) has released an update.
Polarean Imaging PLC, a leader in advanced MRI technology for lung function, has announced a successful capital raise of $10 million and is initiating an Open Offer to raise an additional $2.5 million by offering new shares to qualifying shareholders. This strategic move aims to further bolster the company’s position in the pulmonary medicine market, where its FDA-approved XENOVIEW™ technology offers a non-invasive, radiation-free imaging solution for chronic respiratory diseases.
For further insights into GB:POLX stock, check out TipRanks’ Stock Analysis page.
